Global In Vivo Toxicology Market to reach USD 7.27 Billion by 2027.Global In Vivo Toxicology Market is valued approximately at USD 5.0 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2021-2027. Increasing pharmaceutical research and development activities and growing demand for personalized medicine are the factors which are driving the growth of In Vivo Toxicology market. Furthermore, increasing demand for humanized animal models will be anticipating the growth of market in forecasted period. For instance: In 2020, Waters Corporation established Immerse Cambridge, a research laboratory in Cambridge. This laboratory will provide a strategic, collaborative space in the community, where Waters partnered with academia and research to accelerate the next generation of scientific advancements. However, stringent regulations and laws for the ethical use of animals in research may impede market growth over the forecast period of 2021-2027.

Global In Vivo Toxicology market analysis on basis of region which includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a significant region across the world in terms of market share due to increasing biomedical research in the US. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to advancement of multi-analyte controls, clinical laboratories providing accurate and precise test results in the region.
Major market player included in this report are:
Charles River Laboratories
The Jackson Laboratory
Envigo
Taconic Biosciences, Inc.
JANVIER LABS
Thermo Fisher Scientific
Danaher Corporation
Waters Corporation
Agilent Technologies
Shimadzu Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product
Instruments
Consumables
Reagents & Kits
Animal Models
By Test Type
Acute
Sub-acute
Sub-chronic
Chronic test type
By Testing facility
Outsourced testing facility
In-house testing facility
By Toxicity End Point
Immunotoxicity
Systemic toxicity
Carcinogenicity
Genotoxicity
Developmental & reproductive toxicity (DART)
Other toxicity endpoints
By End User
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global In Vivo Toxicology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors